Both in Pharmaceuticals
Aardvark Therapeutics vs TransCode Therapeutics
Over the past year AARD returned −88.2% and RNAZ returned −85.1%; their daily moves had a correlation of -0.02.
AARD −88.2% RNAZ −85.1%Growth of $1, one year, split-adjusted
| Metric | AARD | RNAZ |
|---|---|---|
| Price | $1.23 | $1.57 |
| Market cap | $26.9M | $26.6M |
| Today | +2.50% | −3.68% |
| 1 month | −76.4% | −10.8% |
| 6 months | −77.5% | −80.0% |
| Year to date | −90.6% | −77.0% |
| 1 year | −88.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $73.9M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 240.8% | 75.6% |
| Short % of float | 4.6% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).